Rosenblatt Rates Dolby Laboratories (DLB) buy, $85 Price Target
Rosenblatt's analyst keeps a bullish outlook on Dolby, setting an $85 price target, a 59.06% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Rosenblatt rated Dolby Laboratories, Inc. ($DLB) "buy" with a $85 price target on June 11, 2026.
Since the rating, $DLB is down 0.7% after 1 week, down 6.4% after 1 month and up 14.4% to date (from the $52.42 close on Jun 11, 2026).
DLB
Dolby Laboratories, Inc.
Key Points
- Rosenblatt analyst Steven Frankel reiterated a buy rating for Dolby Laboratories, Inc. on June 11, 2026, maintaining an $85 price target.
- Dolby shares are currently trading at $53.44, significantly below the $85 target, indicating potential upside if the firm’s outlook is realized.
- Dolby Laboratories has a market cap of approximately $5.37 billion and a P/E ratio of about 24.4, reflecting its valuation compared to earnings.
Get $DLB trade alerts by text
We text you when insiders, Congress or big funds trade $DLB. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Dolby Laboratories, Inc. alert may contain errors. Disclosures
Rosenblatt Maintains Positive Outlook
On June 11, 2026, analyst Steven Frankel at Rosenblatt reiterated a buy rating for Dolby Laboratories, Inc. (DLB) on the NYSE, with a price target of $85. This follows a consistent stance from the firm, as Frankel has also set the same target in prior updates on July 31 and August 28, 2026.
Comparison with Wall Street Ratings
Rosenblatt's buy rating aligns with a broader positive sentiment around Dolby. Currently, the stock trades at $53.44, well below the price target set by the firm. This suggests that analysts see significant upside potential for the stock if market sentiment turns favorable. The consensus from other analysts has not been publicly disclosed, but Rosenblatt's continued support may influence market perceptions.
Stock Performance Context
Dolby shares have shown volatility recently, trading significantly below their 52-week high of $73.01. The stock has a P/E ratio of about 24.4, indicating how investors are valuing the company's earnings. Given the current market conditions, the stock price could be seen as undervalued compared to the potential upside indicated by the $85 target.
$DLB price target
Dolby Laboratories, Inc. daily closes and this analyst's $85 target. Not advice.
Company Background
Dolby Laboratories, Inc. specializes in designing and manufacturing audio and imaging technologies for both entertainment and communication industries. Its innovations, including Dolby Atmos and Dolby Vision, are widely recognized and used across various platforms, enhancing the quality of sound and visuals in media. With a market cap of around $5.37 billion, the company continues to play a crucial role in shaping audio and visual standards in the industry.
Next Steps for Investors
Looking ahead, investors will want to keep an eye on Dolby's next earnings report, which is expected on November 17, 2026. This report may provide further insights into the company's financial health and future performance. As always, the recent 13F filings reflect past holdings and may not represent the current trading positions of analysts or funds. With Rosenblatt's reiterated buy rating, market watchers will be interested to see how the stock performs leading up to the earnings date.
Related Filing Alerts
Source: Rosenblatt's rating change on $DLB (Jun 11, 2026). Written by software, not financial advice. How we make alerts